Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

441 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclooxygenase inhibition in cancer prevention and treatment.
Anderson WF, Umar A, Hawk ET. Anderson WF, et al. Among authors: umar a. Expert Opin Pharmacother. 2003 Dec;4(12):2193-204. doi: 10.1517/14656566.4.12.2193. Expert Opin Pharmacother. 2003. PMID: 14640918 Review.
COX-2 is overexpressed during carcinogenesis, and appears to have a role in both tumour initiation and promotion and is amenable to intervention. ...A brief discussion on the pharmacoeconomic considerations of NSAID and COXIB use and safety issues that have recently …
COX-2 is overexpressed during carcinogenesis, and appears to have a role in both tumour initiation and promotion and is amenable to i …
The future of colon cancer prevention.
Umar A, Viner JL, Hawk ET. Umar A, et al. Ann N Y Acad Sci. 2001 Dec;952:88-108. doi: 10.1111/j.1749-6632.2001.tb02730.x. Ann N Y Acad Sci. 2001. PMID: 11795446 Review.
Chemoprevention of colorectal carcinogenesis.
Umar A, Viner JL, Richmond E, Anderson WF, Hawk ET. Umar A, et al. Int J Clin Oncol. 2002 Feb;7(1):2-26. doi: 10.1007/s101470200001. Int J Clin Oncol. 2002. PMID: 11942045 Review.
Carcinogenesis is now recognized as a disease in itself and has become the target of an ever-expanding array of preventive interventions....
Carcinogenesis is now recognized as a disease in itself and has become the target of an ever-expanding array of preventive interventi …
The role of cyclooxygenase inhibitors in cancer prevention.
Anderson WF, Umar A, Viner JL, Hawk ET. Anderson WF, et al. Among authors: umar a. Curr Pharm Des. 2002;8(12):1035-62. doi: 10.2174/1381612023394935. Curr Pharm Des. 2002. PMID: 11945150 Review.
Chemoprevention of colorectal cancer: problems, progress, and prospects.
Viner JL, Umar A, Hawk ET. Viner JL, et al. Among authors: umar a. Gastroenterol Clin North Am. 2002 Dec;31(4):971-99. doi: 10.1016/s0889-8553(02)00055-9. Gastroenterol Clin North Am. 2002. PMID: 12489273 Review.
Chemoprevention holds great promise as a complement to traditional CRC screening and treatment. Effective chemopreventive agents might improve patient outcomes by reducing the number of missed lesions, the morbidity associated with their identification and treatment, and t …
Chemoprevention holds great promise as a complement to traditional CRC screening and treatment. Effective chemopreventive agents migh …
Epigenetics in cancer prevention: early detection and risk assessment: introduction.
Dunn BK, Verma M, Umar A. Dunn BK, et al. Among authors: umar a. Ann N Y Acad Sci. 2003 Mar;983:1-4. doi: 10.1111/j.1749-6632.2003.tb05957.x. Ann N Y Acad Sci. 2003. PMID: 12724207 No abstract available.
DNA methylation as a cancer-specific biomarker: from molecules to populations.
Patel A, Groopman JD, Umar A. Patel A, et al. Among authors: umar a. Ann N Y Acad Sci. 2003 Mar;983:286-97. doi: 10.1111/j.1749-6632.2003.tb05983.x. Ann N Y Acad Sci. 2003. PMID: 12724233 Review.
Cancer contributes to a large proportion of the mortality and morbidity in the United States and worldwide. Despite advances in diagnosis and treatment of various cancers, early detection and treatment of cancer remain a challenge. ...Thus, the challenge is to valid …
Cancer contributes to a large proportion of the mortality and morbidity in the United States and worldwide. Despite advances in diagn …
Early detection and risk assessment: proceedings and recommendations from the Workshop on Epigenetics in Cancer Prevention.
Verma M, Dunn BK, Ross S, Jain P, Wang W, Hayes R, Umar A. Verma M, et al. Among authors: umar a. Ann N Y Acad Sci. 2003 Mar;983:298-319. doi: 10.1111/j.1749-6632.2003.tb05984.x. Ann N Y Acad Sci. 2003. PMID: 12724234
Recent advances in molecular biology that have provided a greater understanding of multistage carcinogenesis include the use of biomarkers of early detection and risk assessment. ...The field of epigenetics has seen a recent surge of interest among cancer researcher …
Recent advances in molecular biology that have provided a greater understanding of multistage carcinogenesis include the use of bioma …
Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.
Hawk ET, Viner JL, Umar A. Hawk ET, et al. Among authors: umar a. Prog Exp Tumor Res. 2003;37:210-42. doi: 10.1159/000071375. Prog Exp Tumor Res. 2003. PMID: 12795057 Review. No abstract available.
Development of COX inhibitors in cancer prevention and therapy.
Umar A, Viner JL, Anderson WF, Hawk ET. Umar A, et al. Am J Clin Oncol. 2003 Aug;26(4):S48-57. doi: 10.1097/01.COC.0000074157.28792.02. Am J Clin Oncol. 2003. PMID: 12902856 Review.
The National Cancer Institute has a substantial research portfolio dedicated to the identification, testing, and development of NSAIDs as preventive and therapeutic anticancer agents. ...
The National Cancer Institute has a substantial research portfolio dedicated to the identification, testing, and development of NSAID …
441 results
Jump to page
Feedback